Uric acid versus metabolic syndrome as markers of fatty liver disease in young people with overweight/obesity.

HUA represents a useful marker of FLD in youths with OW/OB, given its greater ability to identify those at increased risk of the disease compared to MetS. The ability of both to predict incident FLD must be investigated in longitudinal study.